Syk Inhibition Reprograms Tumor-Associated Macrophages and Overcomes Gemcitabine-Induced Immunosuppression in Pancreatic Ductal AdenocarcinomaDeepak Rohila, Shweta Joshi|Cancer Research|2023Cited by 42
Targeting macrophage Syk enhances responses to immune checkpoint blockade and radiotherapy in high-risk neuroblastomaDeepak Rohila, Shweta Joshi|Frontiers in Immunology|2023Cited by 17